Tag: Etrasimod

According to clinical trial data, Velsipity helped a significantly higher proportion of patients achieve clinical remission compared to placebo. So, what is Velsipity? It is an oral medication that offers a new and convenient treatment option for adults with moderately to severely active ulcerative colitis.

While the query refers to a non-existent 'Velsipity ocular' medication, vision-related side effects are a possibility with the oral tablet formulation used for ulcerative colitis. The most significant visual risk is macular edema, which can lead to blurred vision and potentially permanent loss of sight if left unaddressed.

According to FDA prescribing information, Velsipity is not recommended for people with certain serious heart conditions, such as a heart attack or stroke within the last six months. Understanding **who should not take Velsipity** is crucial for patient safety and effective treatment of ulcerative colitis.